batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Jazz sets zani sights on a post-Enhertu world 5 June 2024 PureTech has company in galectin-9 5 June 2024 ASCO 2024 – Yervoy makes the difference in front-line liver cancer 4 June 2024 ASCO 2024 – IDRx shoots for an early-line gist 3 June 2024 ASCO 2024 – acasunlimab impresses on overall survival 2 June 2024 ASCO 2024 – USP1 lives on, for now 2 June 2024 ASCO 2024 – Pfizer’s KAT6 inhibitor purrs 2 June 2024 ASCO 2024 – two more Echelon-3 surprises 2 June 2024 Load More